Generic Crestor Approved by FDA

Share this content:
Generic Crestor Approved by FDA
Generic Crestor Approved by FDA

FRIDAY, April 29, 2016 (HealthDay News) -- The first generic version of Crestor (rosuvastatin calcium) tablets was approved Friday by the U.S. Food and Drug Administration.

Watson Pharmaceuticals Inc. of New Jersey received approval to market generic rosuvastatin calcium in multiple strengths for certain uses.

These uses include: in combination with diet for the treatment of hypertriglyceridemia in adults, in combination with diet for treatment of patients with primary dysbetalipoproteinemia (type III hyperlipoproteinemia), and either alone or in combination with other cholesterol treatment(s) for adult patients with homozygous familial hypercholesterolemia.

"The FDA is working hard to get first-time generic drugs approved as quickly as possible so patients can have increased access to needed treatments," Kathleen Uhl, M.D., director of the Office of Generic Drugs in the FDA's Center for Drug Evaluation and Research, said in a statement. "The FDA requires that generic drugs meet rigorous scientific and quality standards."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC: Too Many Health Care Workers Not Getting Flu Vaccine

CDC: Too Many Health Care Workers Not Getting ...

Vaccination protects both workers and patients

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Patients discharged sooner, become more functional when they leave the hospital

is free, fast, and customized just for you!

Already a member?

Sign In Now »